Cart
sales@molnova.com
Sulfamethoxypyridazine
CAS No. 80-35-3
Sulfamethoxypyridazine ( Sulfamethoxypyridazine; Lisulfen; Longin; Medicel; Midicel; Midikel; Myasul )
Catalog No. M16007 CAS No. 80-35-3
Sulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 30 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | 54 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSulfamethoxypyridazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.
-
DescriptionSulfamethoxypyridazine is a long-acting sulfonamide for treatment of Dermatitis herpetiformis.
-
SynonymsSulfamethoxypyridazine; Lisulfen; Longin; Medicel; Midicel; Midikel; Myasul
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number80-35-3
-
Formula Weight280.30
-
Molecular FormulaC11H12N4O3S
-
Purity>98%(HPLC)
-
SolubilityDMSO: 56 mg/mL (199.78 mM)
-
SMILESO=S(C1=CC=C(N)C=C1)(NC2=NN=C(OC)C=C2)=O
-
Chemical NameBenzenesulfonamide, 4-amino-N-(6-methoxy-3-pyridazinyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tafintseva Iiu, et al. Prikl Biokhim Mikrobiol. 2010 Mar-Apr; 46(2):232-6.
molnova catalog
related products
-
Toddaculin
Toddaculine may be beneficial for the prevention and treatment of osteoporosis, it can not only inhibit the differentiation of osteoclasts via activation of the NF-κB, ERK 1/2, and p38 MAPK signaling pathways.
-
Crocin
General descriptionA highly unsaturared diterpene dicarboxylic acid ester found in saffron.
-
Anemarrhenasaponin A...
Anemarrhenasaponin A2 (Schidigerasaponin F2) is a steroidal saponin isolated from the rhizomes of Anemarrhena asphodeloides. Anemarrhenasaponin A2 inhibits ADP-induced platelet aggregation.
